 | • レポートコード：QYR2104Z4866 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肺/呼吸器用ドラッグデリバリーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤）、用途別市場規模（病院、在宅医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肺/呼吸器用ドラッグデリバリーの市場動向 ・企業の競争状況、市場シェア ・肺/呼吸器用ドラッグデリバリーの種類別市場規模（懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤） ・肺/呼吸器用ドラッグデリバリーの用途別市場規模（病院、在宅医療） ・肺/呼吸器用ドラッグデリバリーの北米市場規模2016-2027（アメリカ、カナダ） ・肺/呼吸器用ドラッグデリバリーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺/呼吸器用ドラッグデリバリーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺/呼吸器用ドラッグデリバリーの中南米市場規模2016-2027（メキシコ、ブラジル） ・肺/呼吸器用ドラッグデリバリーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Teva Pharmaceutical、3M、Astrazeneca、Boehringer Ingelheim、Cipla、Glaxosmithkline、Novartis、Omron Corporation、Sunovion Pharmaceuticals） ・結論 |
Market Analysis and Insights: Global Pulmonary/ Respiratory Drug Delivery Market
The global Pulmonary/ Respiratory Drug Delivery market size is projected to reach US$ 40770 million by 2026, from US$ 31560 million in 2019, at a CAGR of 3.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pulmonary/ Respiratory Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pulmonary/ Respiratory Drug Delivery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pulmonary/ Respiratory Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pulmonary/ Respiratory Drug Delivery market.
Global Pulmonary/ Respiratory Drug Delivery Scope and Market Size
Pulmonary/ Respiratory Drug Delivery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary/ Respiratory Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Suspension Aerosol
Solution Aerosol
Dry Powder Formulation
Segment by Application
Hospitals
Home Care
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Teva Pharmaceutical
3M
Astrazeneca
Boehringer Ingelheim
Cipla
Glaxosmithkline
Novartis
Omron Corporation
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary/ Respiratory Drug Delivery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Suspension Aerosol
1.2.3 Solution Aerosol
1.2.4 Dry Powder Formulation
1.3 Market by Application
1.3.1 Global Pulmonary/ Respiratory Drug Delivery Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary/ Respiratory Drug Delivery Market Perspective (2016-2027)
2.2 Pulmonary/ Respiratory Drug Delivery Growth Trends by Regions
2.2.1 Pulmonary/ Respiratory Drug Delivery Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pulmonary/ Respiratory Drug Delivery Historic Market Share by Regions (2016-2021)
2.2.3 Pulmonary/ Respiratory Drug Delivery Forecasted Market Size by Regions (2022-2027)
2.3 Pulmonary/ Respiratory Drug Delivery Industry Dynamic
2.3.1 Pulmonary/ Respiratory Drug Delivery Market Trends
2.3.2 Pulmonary/ Respiratory Drug Delivery Market Drivers
2.3.3 Pulmonary/ Respiratory Drug Delivery Market Challenges
2.3.4 Pulmonary/ Respiratory Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pulmonary/ Respiratory Drug Delivery Players by Revenue
3.1.1 Global Top Pulmonary/ Respiratory Drug Delivery Players by Revenue (2016-2021)
3.1.2 Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share by Players (2016-2021)
3.2 Global Pulmonary/ Respiratory Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pulmonary/ Respiratory Drug Delivery Revenue
3.4 Global Pulmonary/ Respiratory Drug Delivery Market Concentration Ratio
3.4.1 Global Pulmonary/ Respiratory Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary/ Respiratory Drug Delivery Revenue in 2020
3.5 Pulmonary/ Respiratory Drug Delivery Key Players Head office and Area Served
3.6 Key Players Pulmonary/ Respiratory Drug Delivery Product Solution and Service
3.7 Date of Enter into Pulmonary/ Respiratory Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pulmonary/ Respiratory Drug Delivery Breakdown Data by Type
4.1 Global Pulmonary/ Respiratory Drug Delivery Historic Market Size by Type (2016-2021)
4.2 Global Pulmonary/ Respiratory Drug Delivery Forecasted Market Size by Type (2022-2027)
5 Pulmonary/ Respiratory Drug Delivery Breakdown Data by Application
5.1 Global Pulmonary/ Respiratory Drug Delivery Historic Market Size by Application (2016-2021)
5.2 Global Pulmonary/ Respiratory Drug Delivery Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pulmonary/ Respiratory Drug Delivery Market Size (2016-2027)
6.2 North America Pulmonary/ Respiratory Drug Delivery Market Size by Type
6.2.1 North America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021)
6.2.2 North America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2022-2027)
6.2.3 North America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2027)
6.3 North America Pulmonary/ Respiratory Drug Delivery Market Size by Application
6.3.1 North America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2021)
6.3.2 North America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2022-2027)
6.3.3 North America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2027)
6.4 North America Pulmonary/ Respiratory Drug Delivery Market Size by Country
6.4.1 North America Pulmonary/ Respiratory Drug Delivery Market Size by Country (2016-2021)
6.4.2 North America Pulmonary/ Respiratory Drug Delivery Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pulmonary/ Respiratory Drug Delivery Market Size (2016-2027)
7.2 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Type
7.2.1 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021)
7.2.2 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Type (2022-2027)
7.2.3 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2027)
7.3 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Application
7.3.1 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2021)
7.3.2 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Application (2022-2027)
7.3.3 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2027)
7.4 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Country
7.4.1 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Country (2016-2021)
7.4.2 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size (2016-2027)
8.2 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Type
8.2.1 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2027)
8.3 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Application
8.3.1 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2027)
8.4 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Region
8.4.1 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pulmonary/ Respiratory Drug Delivery Market Size (2016-2027)
9.2 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Type
9.2.1 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021)
9.2.2 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2022-2027)
9.2.3 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2027)
9.3 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Application
9.3.1 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2021)
9.3.2 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2022-2027)
9.3.3 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2027)
9.4 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Country
9.4.1 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Country (2016-2021)
9.4.2 Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size (2016-2027)
10.2 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Type
10.2.1 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2027)
10.3 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Application
10.3.1 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2027)
10.4 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Country
10.4.1 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Pulmonary/ Respiratory Drug Delivery Introduction
11.1.4 Merck Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Details
11.2.2 Teva Pharmaceutical Business Overview
11.2.3 Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Introduction
11.2.4 Teva Pharmaceutical Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
11.2.5 Teva Pharmaceutical Recent Development
11.3 3M
11.3.1 3M Company Details
11.3.2 3M Business Overview
11.3.3 3M Pulmonary/ Respiratory Drug Delivery Introduction
11.3.4 3M Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
11.3.5 3M Recent Development
11.4 Astrazeneca
11.4.1 Astrazeneca Company Details
11.4.2 Astrazeneca Business Overview
11.4.3 Astrazeneca Pulmonary/ Respiratory Drug Delivery Introduction
11.4.4 Astrazeneca Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
11.4.5 Astrazeneca Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Introduction
11.5.4 Boehringer Ingelheim Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Pulmonary/ Respiratory Drug Delivery Introduction
11.6.4 Cipla Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Glaxosmithkline
11.7.1 Glaxosmithkline Company Details
11.7.2 Glaxosmithkline Business Overview
11.7.3 Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Introduction
11.7.4 Glaxosmithkline Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
11.7.5 Glaxosmithkline Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Pulmonary/ Respiratory Drug Delivery Introduction
11.8.4 Novartis Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Omron Corporation
11.9.1 Omron Corporation Company Details
11.9.2 Omron Corporation Business Overview
11.9.3 Omron Corporation Pulmonary/ Respiratory Drug Delivery Introduction
11.9.4 Omron Corporation Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
11.9.5 Omron Corporation Recent Development
11.10 Sunovion Pharmaceuticals
11.10.1 Sunovion Pharmaceuticals Company Details
11.10.2 Sunovion Pharmaceuticals Business Overview
11.10.3 Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Introduction
11.10.4 Sunovion Pharmaceuticals Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
11.10.5 Sunovion Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pulmonary/ Respiratory Drug Delivery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Suspension Aerosol
Table 3. Key Players of Solution Aerosol
Table 4. Key Players of Dry Powder Formulation
Table 5. Global Pulmonary/ Respiratory Drug Delivery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pulmonary/ Respiratory Drug Delivery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pulmonary/ Respiratory Drug Delivery Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pulmonary/ Respiratory Drug Delivery Market Share by Regions (2016-2021)
Table 9. Global Pulmonary/ Respiratory Drug Delivery Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pulmonary/ Respiratory Drug Delivery Market Share by Regions (2022-2027)
Table 11. Pulmonary/ Respiratory Drug Delivery Market Trends
Table 12. Pulmonary/ Respiratory Drug Delivery Market Drivers
Table 13. Pulmonary/ Respiratory Drug Delivery Market Challenges
Table 14. Pulmonary/ Respiratory Drug Delivery Market Restraints
Table 15. Global Pulmonary/ Respiratory Drug Delivery Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pulmonary/ Respiratory Drug Delivery Market Share by Players (2016-2021)
Table 17. Global Top Pulmonary/ Respiratory Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary/ Respiratory Drug Delivery as of 2020)
Table 18. Ranking of Global Top Pulmonary/ Respiratory Drug Delivery Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pulmonary/ Respiratory Drug Delivery Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pulmonary/ Respiratory Drug Delivery Product Solution and Service
Table 22. Date of Enter into Pulmonary/ Respiratory Drug Delivery Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share by Type (2016-2021)
Table 26. Global Pulmonary/ Respiratory Drug Delivery Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pulmonary/ Respiratory Drug Delivery Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share by Application (2016-2021)
Table 30. Global Pulmonary/ Respiratory Drug Delivery Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pulmonary/ Respiratory Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pulmonary/ Respiratory Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pulmonary/ Respiratory Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pulmonary/ Respiratory Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pulmonary/ Respiratory Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pulmonary/ Respiratory Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pulmonary/ Respiratory Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 62. Merck Company Details
Table 63. Merck Business Overview
Table 64. Merck Pulmonary/ Respiratory Drug Delivery Product
Table 65. Merck Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Teva Pharmaceutical Company Details
Table 68. Teva Pharmaceutical Business Overview
Table 69. Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Product
Table 70. Teva Pharmaceutical Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021) & (US$ Million)
Table 71. Teva Pharmaceutical Recent Development
Table 72. 3M Company Details
Table 73. 3M Business Overview
Table 74. 3M Pulmonary/ Respiratory Drug Delivery Product
Table 75. 3M Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021) & (US$ Million)
Table 76. 3M Recent Development
Table 77. Astrazeneca Company Details
Table 78. Astrazeneca Business Overview
Table 79. Astrazeneca Pulmonary/ Respiratory Drug Delivery Product
Table 80. Astrazeneca Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021) & (US$ Million)
Table 81. Astrazeneca Recent Development
Table 82. Boehringer Ingelheim Company Details
Table 83. Boehringer Ingelheim Business Overview
Table 84. Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Product
Table 85. Boehringer Ingelheim Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021) & (US$ Million)
Table 86. Boehringer Ingelheim Recent Development
Table 87. Cipla Company Details
Table 88. Cipla Business Overview
Table 89. Cipla Pulmonary/ Respiratory Drug Delivery Product
Table 90. Cipla Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021) & (US$ Million)
Table 91. Cipla Recent Development
Table 92. Glaxosmithkline Company Details
Table 93. Glaxosmithkline Business Overview
Table 94. Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Product
Table 95. Glaxosmithkline Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021) & (US$ Million)
Table 96. Glaxosmithkline Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021) & (US$ Million)
Table 100. Novartis Recent Development
Table 101. Omron Corporation Company Details
Table 102. Omron Corporation Business Overview
Table 103. Omron Corporation Pulmonary/ Respiratory Drug Delivery Product
Table 104. Omron Corporation Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021) & (US$ Million)
Table 105. Omron Corporation Recent Development
Table 106. Sunovion Pharmaceuticals Company Details
Table 107. Sunovion Pharmaceuticals Business Overview
Table 108. Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Product
Table 109. Sunovion Pharmaceuticals Revenue in Pulmonary/ Respiratory Drug Delivery Business (2016-2021) & (US$ Million)
Table 110. Sunovion Pharmaceuticals Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary/ Respiratory Drug Delivery Market Share by Type: 2020 VS 2027
Figure 2. Suspension Aerosol Features
Figure 3. Solution Aerosol Features
Figure 4. Dry Powder Formulation Features
Figure 5. Global Pulmonary/ Respiratory Drug Delivery Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Home Care Case Studies
Figure 8. Pulmonary/ Respiratory Drug Delivery Report Years Considered
Figure 9. Global Pulmonary/ Respiratory Drug Delivery Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pulmonary/ Respiratory Drug Delivery Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pulmonary/ Respiratory Drug Delivery Market Share by Regions: 2020 VS 2027
Figure 12. Global Pulmonary/ Respiratory Drug Delivery Market Share by Regions (2022-2027)
Figure 13. Global Pulmonary/ Respiratory Drug Delivery Market Share by Players in 2020
Figure 14. Global Top Pulmonary/ Respiratory Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary/ Respiratory Drug Delivery as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pulmonary/ Respiratory Drug Delivery Revenue in 2020
Figure 16. Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share by Type (2016-2021)
Figure 17. Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share by Type (2022-2027)
Figure 18. North America Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pulmonary/ Respiratory Drug Delivery Market Share by Type (2016-2027)
Figure 20. North America Pulmonary/ Respiratory Drug Delivery Market Share by Application (2016-2027)
Figure 21. North America Pulmonary/ Respiratory Drug Delivery Market Share by Country (2016-2027)
Figure 22. United States Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pulmonary/ Respiratory Drug Delivery Market Share by Type (2016-2027)
Figure 26. Europe Pulmonary/ Respiratory Drug Delivery Market Share by Application (2016-2027)
Figure 27. Europe Pulmonary/ Respiratory Drug Delivery Market Share by Country (2016-2027)
Figure 28. Germany Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Share by Region (2016-2027)
Figure 38. China Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pulmonary/ Respiratory Drug Delivery Market Share by Type (2016-2027)
Figure 46. Latin America Pulmonary/ Respiratory Drug Delivery Market Share by Application (2016-2027)
Figure 47. Latin America Pulmonary/ Respiratory Drug Delivery Market Share by Country (2016-2027)
Figure 48. Mexico Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Pulmonary/ Respiratory Drug Delivery Market Share by Country (2016-2027)
Figure 54. Turkey Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
Figure 58. Teva Pharmaceutical Revenue Growth Rate in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
Figure 59. 3M Revenue Growth Rate in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
Figure 60. Astrazeneca Revenue Growth Rate in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
Figure 62. Cipla Revenue Growth Rate in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
Figure 63. Glaxosmithkline Revenue Growth Rate in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
Figure 65. Omron Corporation Revenue Growth Rate in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
Figure 66. Sunovion Pharmaceuticals Revenue Growth Rate in Pulmonary/ Respiratory Drug Delivery Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の在宅用呼吸療法市場規模・現状・予測（2021年-2027年） Having access to home respiratory care is not a luxury for seriously ill patients; it’s often a lifesaving necessity. For the millions of people struggling with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea, home respiratory care is vital for i…- 世界の在宅用呼吸療法市場規模・現状・予測（2021年-2027年） Having access to home respiratory care is not a luxury for seriously ill patients; it’s often a lifesaving necessity. For the millions of people struggling with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea, home respiratory care is vital for i…
- 世界のドラッグデリバリー技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Delivery Technologies Market The global Drug Delivery Technologies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界のドラッグデリバリー技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Delivery Technologies Market The global Drug Delivery Technologies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の鎮痛剤デリバリー市場規模・現状・予測（2021年-2027年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…